ArticleRSC advances2022

Mitochondria-targeted half-sandwich iridium(iii)-Cp*-arylimidazophenanthroline complexes as antiproliferative and bioimaging agents against triple negative breast cancer cells MDA-MB-468.

Ashaparna Mondal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.